Novartis AG (NOVN) - Stock Price & Dividends

Exchange: SIX Swiss Exchange • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0012005267

(SW:NOVN Stock) Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Novartis AG (NOVN) - Stock Price & Dividends

NOVN Stock Overview

Market Cap in USD 204,836m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception

NOVN Stock Ratings

Fundamental 6.34
Dividend 7.05
Growth 5y 4.76
Rel. Performance vs Sector 1.03
Analysts -
Fair Price Total Ret. 87.49
Fair Price DCF 151.54

NOVN Dividends

Yield 12m 3.55%
Yield on Cost 5y 5.14%
Dividends CAGR 5y 2.34%
Payout Consistency 100.0%

NOVN Growth Ratios

Growth 12m 22.37%
Growth Correlation 12m 42%
Growth Correlation 3m 32%
CAGR 5y 7.62%
CAGR / Mean Drawdown 1.06
Sharpe Ratio 12m 0.96
Alpha vs SP500 12m 8.65
Beta vs SP500 5y weekly 0.40
CAPM 6.31%
Average Daily Range 2m 1.30%
Regime Oscillator 55.00
Volatility GJR Garch 1y 21.27%
Price / SMA 50 0.94%
Price / SMA 200 4.3%
Current Volume 2379.3k
Average Volume 20d 3009.6k

External Links for NOVN Stock

X (Twitter)Stocktwits
Fund Manager Positions
What is the price of NOVN stocks?
As of February 22, 2024, the stock is trading at CHF 90.04 with a total of 2,379,308 shares traded.
Over the past week, the price has changed by +2.55%, over one month by -4.62%, over three months by +5.84% and over the past year by +22.96%.
Why is NOVN stock down?
Check with which Index or Commodity NOVN has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return NOVN Return S&P 500
1 Month -4.62% 2.85%
3 Months 5.84% 10.14%
12 Months 22.96% 26.48%
What is the forecast for NOVN stock price target?
According to ValueRays Forecast Model, NOVN Novartis AG will be worth about 94.5 in February 2025. The stock is currently trading at 90.04. This means that the stock has a potential upside of +4.94%.
Issuer Forecast Upside
Wallstreet Target Price 86.9 -3.5%
Analysts Target Price - -
ValueRay Target Price 94.5 4.9%